Understanding CLIA-Certified Genetic Testing Laboratories
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 established federal quality standards for all clinical laboratory testing in the United States. For genetic testing, CLIA certification is the baseline regulatory requirement ensuring that a laboratory meets standards for accuracy, reliability, and quality control in delivering test results used for patient care.
The Regulatory Landscape
All U.S. laboratories performing genetic tests on human specimens must hold a valid CLIA certificate issued by the Centers for Medicare & Medicaid Services (CMS). There are several certificate types:
- Certificate of Accreditation (CoA)
- Issued to labs accredited by CMS-approved organizations such as the College of American Pathologists (CAP). Most high-complexity genetic testing labs hold this certificate.
- Certificate of Compliance (CoC)
- Issued to labs that pass direct CMS inspection rather than going through an accrediting body.
Scale of the Industry
According to the NIH Genetic Testing Registry (GTR), approximately 780 laboratories in the United States are registered as offering clinical genetic tests. These range from large commercial reference laboratories processing millions of samples annually—such as Labcorp Genetics (formerly Invitae) and Natera, which has processed over 12 million tests—to academic medical center labs and specialized boutique facilities focusing on rare disease diagnostics.
Key Testing Categories
| Category | Examples | Primary Buyers |
|---|---|---|
| Hereditary Cancer Panels | BRCA1/2, Lynch syndrome, Li-Fraumeni | Oncologists, genetic counselors |
| Whole Exome/Genome Sequencing | Diagnostic odyssey, undiagnosed conditions | Rare disease specialists, pediatric geneticists |
| Prenatal/Reproductive | NIPT, carrier screening, PGT | OB/GYNs, reproductive endocrinologists |
| Pharmacogenomics | Drug metabolism panels, CYP450 testing | Prescribing physicians, health systems |
| Cytogenetics | Karyotyping, FISH, chromosomal microarray | Hematologists, neonatologists |
Choosing a Lab for Referral or Partnership
Beyond CLIA certification, clinicians and biotech teams evaluating genetic testing partners should verify:
- CAP accreditation — considered the gold standard for laboratory quality beyond base CLIA compliance
- State-specific licenses — states like New York (through the Wadsworth Center) and California impose additional requirements
- GTR registration — labs voluntarily submitting data to the NIH Genetic Testing Registry demonstrate transparency about their test offerings and validation
- Turnaround time and variant interpretation — particularly important for time-sensitive clinical decisions in oncology or prenatal care